BioNJ Annual Dinner Meeting Committee

BioNJ Members collaborate to plan the agenda for the February BioNJ Annual Dinner Meeting and Innovation Celebration; a celebratory dinner meeting and networking event honoring New Jersey’s innovators and the Patients who inspire them.

Committee Members:

Amicus Therapeutics, Inc. – Jayne Gershkowitz, Chief Patient Advocate
Amicus Therapeutics, Inc. – Michael Losow, JD, MBA, Director, Patient & Professional Advocacy
Amicus Therapeutics, Inc. – Sara Pellegrino, Vice President, Investor Relations & Corporate Communications
Ashton Tweed, LTD – Jordan Warshafsky, MBA, Partner
Chemical & Pharmaceutical Solutions – James Bruno, MBA, Managing Director
Colliers International – Jack Callahan, Associate Director
Deloitte – Brian Wilcomes, CPA, Partner
Eli Lilly & Company – Tracy Henrikson, MBA, Vice President, Corporate Communications
EY – Tony Torrington, CPA, Partner
EY – Joel Wagner, CPA, Assurance Senior Manager
Franzwa Real Estate Advisors, LLC – Mary Ryan, President
Infinity Resources, LLC – Harriet Maphet, MBA, President
JBK Associates International – Steve Prisco, MBA, Principal
Jones Lang LaSalle – John Cahill, Senior Vice President
LeaderStrong – Marshall Calman, MBA, PCC, Co-Founder & Principal
LeaderStrong – Jack Levitt, MBA, EMTM, Co-Founder & Principal
Marsh, Inc. – Bill DeStefano, Vice President, Life Science Practice
New Jersey Institute of Technology (NJIT) – Judith Sheft, MBA, MSc, Associate Vice President, Technology Development
Soligenix, Inc. – Christopher Schaber, Ph.D., President & CEO
VelocIT powered by DSi – Darek Hahn, President & CEO